目的：探讨慢性重型病毒性肝炎患者低钠血症的治疗。
Objective: To discuss the treatment of viral chronic severe hepatitis with hyponatremia.
探讨终末期肝病模型(MELD)评分系统对预测慢性重型乙型病毒性肝炎患者短期预后的临床应用价值。
To assess the value of the model for end-stage liver disease (MELD) on the short-term prognosis in the patients with chronic liver failure (chronic and severe hepatitis B).
临床类型以慢性肝炎、重型肝炎多见，其中慢性肝炎最多；
The chronic hepatitis and severe hepatitis were more in the clinical type, and the chronic hepatitis was the most.
目的应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝，进一步评价其安全性和疗效。
Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver.
在肝硬化基础上发生的重型肝炎患者血浆置换的疗效低于在慢性肝炎基础上发生的重型肝炎（P<0.01）；
The plasma exchange's efficacy for chronic severe hepatitis patients with underlying liver cirrhosis were lower than those with chronic hepatitis(P<0.01).
目的：探讨慢性重型病毒性肝炎门静脉系统血流动力学变化。
Purpose: To study the portal vein hemodynamic changes in chronic hepatitis gravis.
方法2 0 2例慢性重型病毒性肝炎患者在不同病期进行肝穿刺作肝脏病理检查。
Methods Liver biopsies were performed by hepatocentesis in different stages of the courses in 202 patients with chronic viral hepatitis gravis.
结果三项指标分别在急性肝炎、慢性肝炎中型、重型和肝硬化中依次升高，差异有显著性（P＜0.01或P＜0.05）。
Results The three markers increase in the AH, CH (moderate type, severe type), cirrhosis progressively while the difference between groups were significant (P<0.01 or P<0.05).
结果三项指标分别在急性肝炎、慢性肝炎中型、重型和肝硬化中依次升高，差异有显著性（P＜0.01或P＜0.05）。
Results The three markers increase in the AH, CH (moderate type, severe type), cirrhosis progressively while the difference between groups were significant (P<0.01 or P<0.05).
应用推荐